1,428
Participants
Start Date
June 30, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
February 28, 2009
APF530
Given subcutanously
dexamethasone
Given IV and orally
Palonosetron Hydrochloride
Given IV
placebo
Given subcutanously or IV
Hudson Valley Hematology-Oncology Associates - Poughkeepsie, Poughkeepsie
Veterans Affairs Medical Center - Buffalo, Buffalo
Falck Cancer Center at Arnot Ogden Medical Center, Elmira
Pottsville Cancer Clinic, Pottsville
Providence Hospital, Washington D.C.
Center for Cancer and Blood Disorders at Suburban Hospital, Bethesda
Center for Clinical Research at Washington County Hospital, Hagerstown
Cancer Outreach Associates - Abingdon, Abingdon
Virginia Oncology Care, PC, Richlands
Boice Willis Clinic, PA, Rocky Mount
Eastern North Carolina Medical Group, PLLC, Rocky Mount
Comprehensive Cancer Center at Pardee Hospital, Hendersonville
Charleston Hematology Oncology Associates, PA, Charleston
Columbus Clinic, PC, Columbus
Pasco Pinellas Cancer Center - New Port Richey, New Port Richey
Anniston Oncology, PC, Anniston
Regional Cancer Center at Singing River Hospital, Pascagoula
Kentuckiana Cancer Institute, PLLC, Louisville
Kentucky Cancer Clinic - Hazard, Hazard
McDowell Cancer Center at Akron General Medical Center, Akron
Gabrail Cancer Center - Dover Office, Dover
Gabrail Cancer Center - Canton Office, Canton
MedCentral - Mansfield Hospital, Mansfield
Signal Point Hematology Oncology Incorporated, Middletown
Investigative Clinical Research, LLC, Indianapolis
Cancer Center of Indiana, New Albany
Family Medicine of Vincennes Clinical Trial Center, Vincennes
Medical Center Vincennes, Vincennes
Northern Michigan Hospital, Petoskey
Clintell, Incorporated, Skokie
Kansas City Cancer Centers - South, Kansas City
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock
Julie and Ben Rogers Cancer Institute at Memorial Hermann Baptist Beaumont Hospital, Beaumont
Texas Cancer Clinic, San Antonio
Palo Verde Hematology Oncology - Glendale, Glendale
Arizona Clinical Research Center, Incorporated, Tucson
Advanced Research Management Services, Incorporated, Los Angeles
Kenmar Research Institute, Los Angeles
Compassionate Cancer Care Medical Group Incorporated - Fountain Valley, Fountain Valley
Pacific Cancer Medical Center, Incorporated, Anaheim
Medical Oncology Care Associates - Orange, Orange
Compassionate Cancer Care Medical Group Incorporated - Corona, Corona
Southbay Oncology / Hematology Medical Group, Campbell
MultiCare Regional Cancer Center at Tacoma General Hospital, Tacoma
Western Washington Oncology, Incorporated, PS at Western Washington Cancer Center, Lacey
Eastern Connecticut Hematology and Oncology Associates, Norwich
Innovative Medical Research of South Florida, Incorporated, North Miami Beach
Hematology-Medical Oncology Associates at Central Maine Comprehensive Cancer Center, Lewiston
Mercy Medical Center, Baltimore
Star Hematology & Oncology, Phillipsburg
Cancer Treatment Centers of America at Southwestern Regional Medical Center, Tulsa
Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown
Lead Sponsor
Heron Therapeutics
INDUSTRY